Abstract:
The invention relates to a high thermal efficiency, insulated glass unit structure sealed with a cured composition containing, inter alia, diorganopolysiloxane(s) and inorganic-organic nanocomposite(s), the cured composition exhibiting low permeability to gas(es).
Abstract:
The present invention provides for a room temperature cured silicone thermoplastic resin sealant composition with reduced gas permeability useful in the manufacture of glazing such as windows and doors.
Abstract:
A projector (100) with automatic focusing assistance includes a focus control (102) for controlling the focus of optics (108) of the projector, and a focus control use sensor. The projector (100) automatically displays a focus assistance element when the focus control use sensor (103) detects use of the focus control (102). A method of operating a projector (100) includes automatically displaying a focus assistance element when a focus control of the projector (100) is used.
Abstract:
A remote control unit (14) configured to operate a display device (12), where the remote control unit includes onboard memory (42), an interface (32) configured to connect with an independent memory device (16), and a processor (44) configured to transfer image data from the independent memory device to the onboard memory via the interface.
Abstract:
The present invention provides improved methods and pharmaceutical compositions for enhancing stem cell engraftment, comprising the administration of an effective amount of a modulator of RhoGTPases.
Abstract:
Chimeric peptides or fusion proteins are disclosed that include a RhoGAP activity domain and at least one specificity domain that targets a specific Rho protein. The fusion proteins can be used to inhibit any GTPase activity within a cell. The fusion proteins are particularly advantageous for the treatment of cancer. The present invention generally relates to The present invention generally relates to chimeric peptides capable of regulating GTPases, and more particularly, to methods of targeting individual GTPases by using GTPase-activating proteins. Such proteins may be used for the treatment of cancers and other GTPase-related diseases. This invention relates to nucleic acid molecules and the encoded GTPase activating proteins, and variants thereof, and to the use of these molecules in the characterization, diagnosis, prevention, and treatment of cell signaling, immune, and cell proliferative disorders, particularly cancer. Disclosed herein are compounds and methods for regulating transcription of a selected gene. Methods are provided for constructing and for using such compounds to regulate transcription of a selected gene.
Abstract:
A curable composition comprising a hydrolysable silyl-containing polymer and a silicone-containing paint adhesion additive that provide curable silyl-containing polymer composition which has improved adhesion of coatings, paints, adhesives, and other surface treatments thereto.
Abstract:
A substantially uniform polyurethane-polysiloxane resin mixture is obtained from a two-part curable composition in which the first part contains a moisture-curable silylated polyurethane resin and a crosslinker for silanol-terminated diorganopolysiloxane, the second part contains silanol-terminated diorganopolysiloxane and a condensation catalyst is present in the first and/or second part.
Abstract:
The present invention provides for a room temperature vulcanizable silicone sealant composition that rapidly achieves a usable green strength shortly after application. Such a composition that develops a usable green strength is useful in the manufacture of architectural elements employing glazing such as windows and doors and when such a composition is used in a manufacturing process, the manufacturing process can be accelerated relative to a process that uses a silicone sealant that does not rapidly achieve a usable green strength.
Abstract:
The present invention provides improved methods and pharmaceutical compositions for enhancing stem cell engraftment, comprising the administration of an effective amount of a modulator of RhoGTPases.